Use of Anti-her3 antibody-drug conjugate and method of use

TW202641592APending Publication Date: 2026-10-16DUALITY BIOLOGICS (SUZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114152003
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-12-10
Filing Date
2025-12-30
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080839_001
    Figure TWG2TA001080839_001
  • Figure TWG2TA001080839_002
    Figure TWG2TA001080839_002
  • Figure TWG2TA001080839_003
    Figure TWG2TA001080839_003
Patent Text Reader

Abstract

The present invention relates to a use of an anti-HER3 antibody-drug conjugate for the treatment of cancer, particularly refractory, advanced / metastatic malignant solid tumors. The present invention also relates to a method for treating cancer using the anti-HER3 antibody-drug conjugate.
Need to check novelty before this filing date? Find Prior Art